Fundacion Oncosur Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial
2019
NCT04253145
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fundacion Oncosur